Gaviscon Chewable
RxNorm concept 1372739, brand name (bn).
- RxCUI
- 1372739
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1372739 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- aluminum hydroxide / magnesium trisilicate Chewable Tablet [Gaviscon Chewable] (SBDF, ingredient of)
- aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG [Gaviscon Chewable] (SBDC, ingredient of)
- aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG Chewable Tablet [Gaviscon Chewable] (SBD, ingredient of)
- Gaviscon Chewable Oral Product (SBDG, ingredient of)
- Gaviscon Chewable Pill (SBDG, ingredient of)
- Gaviscon Chewable Chewable Product (SBDG, ingredient of)
- aluminum hydroxide (IN, tradename of)
- magnesium trisilicate (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1372739 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1372739 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1372739. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.